ATE97813T1 - Mittel zur kontrolle von thrombenbildungen. - Google Patents

Mittel zur kontrolle von thrombenbildungen.

Info

Publication number
ATE97813T1
ATE97813T1 AT89115562T AT89115562T ATE97813T1 AT E97813 T1 ATE97813 T1 AT E97813T1 AT 89115562 T AT89115562 T AT 89115562T AT 89115562 T AT89115562 T AT 89115562T AT E97813 T1 ATE97813 T1 AT E97813T1
Authority
AT
Austria
Prior art keywords
human
csf
control agent
disclosed
thrombus control
Prior art date
Application number
AT89115562T
Other languages
English (en)
Inventor
Koichiro Tsuji
Masayoshi Ono
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ATE97813T1 publication Critical patent/ATE97813T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/53—Colony-stimulating factor [CSF]
    • C07K14/535—Granulocyte CSF; Granulocyte-macrophage CSF
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/14—Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Networks Using Active Elements (AREA)
  • Surgical Instruments (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
AT89115562T 1988-08-24 1989-08-23 Mittel zur kontrolle von thrombenbildungen. ATE97813T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP21037688 1988-08-24
EP89115562A EP0355811B1 (de) 1988-08-24 1989-08-23 Mittel zur Kontrolle von Thrombenbildungen

Publications (1)

Publication Number Publication Date
ATE97813T1 true ATE97813T1 (de) 1993-12-15

Family

ID=16588321

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89115562T ATE97813T1 (de) 1988-08-24 1989-08-23 Mittel zur kontrolle von thrombenbildungen.

Country Status (8)

Country Link
US (1) US5202117A (de)
EP (1) EP0355811B1 (de)
KR (1) KR950003492B1 (de)
AT (1) ATE97813T1 (de)
CA (1) CA1339071C (de)
DE (1) DE68911061T2 (de)
IL (1) IL91423A (de)
ZA (1) ZA896463B (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9120304D0 (en) * 1991-09-24 1991-11-06 Erba Carlo Spa Stable pharmaceutical compositions containing a granulocyte macrophage colony stimulating factor
FR2693907B1 (fr) * 1992-07-23 1994-09-02 Rhone Poulenc Rorer Sa Procédé d'administration de solutions de facteur de stimulation des colonies granulocytaires.
US5879794A (en) * 1994-08-25 1999-03-09 W. L. Gore & Associates, Inc. Adhesive-filler film composite
DE19539574A1 (de) 1995-10-25 1997-04-30 Boehringer Mannheim Gmbh Zubereitungen und Verfahren zur Stabilisierung biologischer Materialien mittels Trocknungsverfahren ohne Einfrieren
AU4902897A (en) 1996-11-08 1998-05-29 W.L. Gore & Associates, Inc. Method for improving reliability of thin circuit substrates by increasing the T of the substrate
JP3895109B2 (ja) * 1998-03-06 2007-03-22 中外製薬株式会社 蛋白非添加製剤
US8435939B2 (en) 2000-09-05 2013-05-07 Biokine Therapeutics Ltd. Polypeptide anti-HIV agent containing the same
US20020198150A1 (en) * 2001-06-07 2002-12-26 Ayelet Chajut Methods of using colony stimulating factors in the treatment of tissue damage and ischemia
EP1541585B1 (de) 2002-08-27 2013-01-30 Biokine Therapeutics Ltd. Cxcr4-antagonist und dessen verwendung
US20090226397A1 (en) * 2003-10-24 2009-09-10 Nora Therapeutics, Inc. Compositions and methods for reducing the likelihood of implantation failure or miscarriage in recipients of artificial insemination
KR100812274B1 (ko) * 2006-10-30 2008-03-13 한양대학교 산학협력단 Ｇ-ｃｓｆ를 유효성분으로 하는 당뇨성 말초신경병 예방 및치료제
WO2008075371A2 (en) 2006-12-21 2008-06-26 Biokine Therapeutics Ltd. T-140 peptide analogs having cxcr4 super-agonist activity for immunomodulation
JP5702150B2 (ja) 2008-02-08 2015-04-15 アンブルックス, インコーポレイテッドAmbrx, Inc. 修飾されているレプチンポリペプチドおよびそれらの使用
UA103774C2 (uk) * 2008-07-23 2013-11-25 Амбркс, Інк. Модифіковані поліпептиди бичачого гранулоцитарного колонієстимулювального фактора (g-csf) та їх застосування
US9155780B2 (en) 2009-02-11 2015-10-13 Yeda Research And Development Co. Ltd. Short beta-defensin-derived peptides
WO2010146578A2 (en) 2009-06-14 2010-12-23 Biokine Therapeutics Ltd. Peptide therapy for increasing platelet levels
TWI480288B (zh) 2010-09-23 2015-04-11 Lilly Co Eli 牛顆粒細胞群落刺激因子及其變體之調配物
EP2841084B1 (de) 2012-04-24 2018-05-30 Biokine Therapeutics Ltd. Cxcr4 antagonist peptid zur verwendung in der behandlung von lungenkrebs
EP3943098A3 (de) 2015-07-16 2022-05-11 Biokine Therapeutics Ltd. Zusammensetzungen und verfahren zur behandlung von krebs
KR102033920B1 (ko) 2016-02-23 2019-10-18 바이오라인알엑스 리미티드 급성 골수성 백혈병을 치료하는 방법

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4766075A (en) * 1982-07-14 1988-08-23 Genentech, Inc. Human tissue plasminogen activator
JPS61227526A (ja) * 1984-07-25 1986-10-09 Chugai Pharmaceut Co Ltd 新規なコロニー刺激因子
KR960008010B1 (ko) * 1988-07-29 1996-06-19 오오쓰까세이야꾸 가부시끼가이샤 IL-1α 유도체 및 혈소판 감소증 치료 약제
JP2805224B2 (ja) * 1989-01-13 1998-09-30 味の素株式会社 血小板減少症治療剤

Also Published As

Publication number Publication date
KR900002800A (ko) 1990-03-23
IL91423A0 (en) 1990-04-29
US5202117A (en) 1993-04-13
EP0355811A2 (de) 1990-02-28
DE68911061D1 (de) 1994-01-13
DE68911061T2 (de) 1994-03-24
AU625914B2 (en) 1992-07-16
EP0355811A3 (de) 1991-03-20
KR950003492B1 (ko) 1995-04-13
AU4014789A (en) 1990-03-01
EP0355811B1 (de) 1993-12-01
IL91423A (en) 1995-06-29
ZA896463B (en) 1990-05-30
CA1339071C (en) 1997-07-29

Similar Documents

Publication Publication Date Title
ATE97813T1 (de) Mittel zur kontrolle von thrombenbildungen.
SE8703625D0 (sv) New medical use
GEP20002146B (en) Therapeutic Peptide Derivatives
ID24901A (id) Metode pengobatan keadaan terkoagulasi tinggi atau defisiensi protein c yang diperoleh
RU93032613A (ru) Фармацевтический препарат для лечения пациентов с пролонгированным временем коагуляции, способ лечения пациентов, применение epi ингибитора для получения фармацевтического препарата
GR3019514T3 (en) Pharmaceutical preparation for the treatment of prolonged coagulation time
DE69734450D1 (de) Photopherese-behandlung von hcv-infektionen
FI904403A0 (fi) Fettsyrabehandling.
ATE89737T1 (de) Behandlung von leukozytstoerungen mit gm-csf.
DE69015910D1 (de) Pharmazeutische Verwendung von Fettsäuren.
GR3032224T3 (en) Therapeutic agent for threatened abortion.
DE68916777D1 (de) Verwendung von TNF zur Herstellung eines Arzneimittels zur Behandlung von Psoriasis.
TWI263502B (en) Pharmaceutical preparation for treating ischemic disease of heart or limbs
GR3000751T3 (en) Tpa-containing medical composition and use thereof
EP0239644A4 (de) Neue physiologisch aktive mittel mit blutkoagulierungsregelnder wirkung.
GR3017672T3 (en) Therapeutic agent for diabetic gangrene.
ATE126437T1 (de) Verwendung von depogen zur behandlung von eingeschränktem blutkreislauf.
DE3876425D1 (de) Gesteuerte verabreichung eines heilmittels an blut.
RU98111356A (ru) Способ лечения ожогового шока

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee